The Bc Bud Stock EBITDA

BCBCF Stock  USD 0.05  0.01  10.61%   
The BC Bud fundamentals help investors to digest information that contributes to BC Bud's financial success or failures. It also enables traders to predict the movement of BCBCF Pink Sheet. The fundamental analysis module provides a way to measure BC Bud's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BC Bud pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

The BC Bud Company EBITDA Analysis

BC Bud's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current BC Bud EBITDA

    
  (2.83 M)  
Most of BC Bud's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The BC Bud is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, The BC Bud reported earnings before interest,tax, depreciation and amortization of (2.83 Million). This is 100.32% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The ebitda for all United States stocks is 100.07% higher than that of the company.

BCBCF EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BC Bud's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BC Bud could also be used in its relative valuation, which is a method of valuing BC Bud by comparing valuation metrics of similar companies.
BC Bud is currently under evaluation in ebitda category among its peers.

BCBCF Fundamentals

About BC Bud Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze The BC Bud's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BC Bud using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The BC Bud based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in BCBCF Pink Sheet

BC Bud financial ratios help investors to determine whether BCBCF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BCBCF with respect to the benefits of owning BC Bud security.